Australia’s active vaccine safety system

  • Pertussis vaccine safety surveillance data

    From 1 July 2018, maternal pertussis vaccine is being funded for pregnant women under the National Immunisation Program. AusVaxSafety is monitoring the safety of maternal pertussis vaccines in the days following immunisation. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

     

     

    Last updated: 10/01/2020

    7,812 Pregnant women responded to an SMS about their health a
    few days after their maternal pertussis vaccinations.

    93.9%
    reported no adverse events

    93.9%
    reported no adverse events


    6.1%
    reported any adverse
    event, including...


    0.5%
    who reported going
    to a doctor or emergency
    department in the days after
    vaccination.

    The adverse events they reported were similar to the types of adverse events reported overall

     

    477 Pregnant women reported one or more adverse events.
    The most commonly reported were:



    These symptoms are known to occur after vaccination. They are generally mild and short-lived.

  • Influenza vaccine safety Surveillance data

    Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

    3,718 Pregnant women responded to an SMS about their health a
    few days after their influenza vaccinations.

    95.5%
    reported no adverse events

    95.5%
    reported no adverse events


    5.5%
    reported any adverse
    event, including...


    0.5%
    who reported going
    to a doctor or emergency
    department in the days after
    vaccination.

    The adverse events they reported were similar to the types of adverse events reported overall

     

    204 Pregnant women reported one or more adverse events.
    The most commonly reported were:



    These symptoms are known to occur after vaccination. They are generally mild and short-lived.